Home › Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses
 

Keywords :   


Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses

2014-11-15 12:08:06| Biotech - Topix.net

The National Institutes of Health awarded Integral Molecular Inc. a five-year, $3.5 million contract to study the human immune response to the Ebola virus and hepatitis C virus. The funding will enable the Philadelphia biotechnology company to better understand how human antibodies protect, or fail to protect, people against such viruses.

Tags: study firm contract philadelphia

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 34
07.07Tropical Storm Beryl Wind Speed Probabilities Number 34
07.07Tropical Storm Beryl Public Advisory Number 34
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
More »